Ioana Alexandra Voda: The Story Gets More Time at IFOS Istanbul
Ioana Alexandra Voda, Senior ENT Physician, Doctor of Medical Sciences at Clinica Nova ORL, shared a post on LinkedIn:
”Apparently, someone heard me.
A few days ago, I wrote about my IFOS Istanbul challenge:
How do you turn a 30-minute scientific presentation into 7 minutes?
Well… I have just received some very good news.
My presentation on Rare Hematological Findings in Vestibular Medicine has been extended from 7 to 20 minutes.
And my presentation on specific vestibular rehabilitation strategies for bilateral areflexia and hyporeflexia of different etiologies will now have 30 minutes- Instructionsl Courses.
Was it LinkedIn?
Was it luck?
Or did the scientific committee simply realize that some stories need a little more time?
I have no idea.
But I am certainly not complaining!
Now I have enough time to explain the clinical reasoning behind the hematological findings — not thrombophilia , policitemia, anemia, histamine pathologies, as an isolated ’cause’, but the possible interaction between hematological/vascular vulnerability, associated factors and a trigger.
And enough time to explain why bilateral vestibular hypofunction is not one single condition — and why vestibular rehabilitation should therefore not be one-size-fits-all.
So… now I have no excuse.
Back to the slides.
See you at IFOS Istanbul!”
Stay updated with Hemostasis Today.
-
Oct 27, 2026, 16:28Rose Agor: Celebrating Two New Publications in Haematology Research
-
Oct 27, 2026, 16:21Pregnancy and Thrombosis-What Clinicians Need to Know – World Thrombosis Day
-
Oct 27, 2026, 16:13Lesley Van Wyk: DIC vs TTP vs HUS – The Key Diagnostic Clues
-
Oct 27, 2026, 16:02Ahmad G. Alzahrani: AF and Vascular Risk Factors – Should We Add Antiplatelet Therapy?
-
Oct 27, 2026, 16:02Iron Deficiency and Thrombocytosis: How Iron Availability Shapes Hematopoietic Lineage Decisions
-
Oct 27, 2026, 15:46Christiane Berger-Schaffitzel: New PhD Project Explores Snake Venom and Haemostasis
-
Oct 27, 2026, 13:51Muhammed Hajmusa: ESMO 2026 Highlights the Challenge of Anticoagulation in ROS1-Positive Lung Cancer
-
Oct 27, 2026, 13:39Luca Galassi: Retrieved Venous Thrombi as a Tool for Predicting Post-Thrombotic Syndrome
-
Oct 27, 2026, 11:43Tareq Abadl: Hidden Interferences Behind Unexpected Laboratory Results